Imuno develops a structure-based discovery engine to identify cancer-specific epitopes.
Imuno has raised $339K in total funding. The most recent round was Seed. The last funding was announced in November 2021.
Imuno's investors include UNIIQ, LEH.
Imuno is headquartered in Leiden, The Netherlands.
Imuno develops a structure-based discovery engine to identify cancer-specific epitopes.
Imuno is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Imuno — Funding & Investors." VCBacked, November 19, 2021, https://www.vcbacked.co/company/imuno. Accessed August 16, 2026.
VCBacked. (2021). Imuno — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/imuno
{{cite web |title=Imuno — Funding & Investors |url=https://www.vcbacked.co/company/imuno |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated